Showing posts with label gynecologic cancers. Show all posts
Showing posts with label gynecologic cancers. Show all posts

Thursday, 17 November 2016

Our Community - 2016 Survey Results

During September and early October we conducted a #gyncsm community survey. We were so pleased that 84 individuals took our survey. This is up from 37 respondents who completed our 2014 #gyncsm survey. We very much appreciate those who took the time to share their ideas and recommendations. Below are some highlights of the results.
 

The majority of survey respondents were Gynecologic Cancer Patient / Survivors (70.0%) followed by High Risk Individual or Advocate / Previvor (12.5%), Health Care Provider (11.25%), Caregiver / Loved One of a gynecologic cancer patient / survivor (10%) and lastly Cancer Researcher (5%).

The patient / survivor breakdown was:

  • 46.8% ovarian
  • 34.3% endometrial/uterine
  • 14.0% cervical
  • 8% fallopian, primary peritoneal, vulvar or GTD
  • 0% vaginal
  • 7.8% breast
Of the health care professionals who filled out the survey, the majority were nurses (42.8%) or gynecologic oncologists (28.5%). The remaining health care professionals were medical oncologists, radiation oncologists, researchers or genetic counselors.
 

We were interested in how followers interacted with the #gyncsm hashtag, chats and community. 43% of the respondents read the chat blog posts, 43% retweeted using the hashtag, 36% took part in a chat, 38% tweeted using #gyncsm, and 27% read a chat transcript. Less than 10% of the respondents joined us on Smart Patients platform. When asked specifically about our blog site, we found that 50% of the respondents visited our blog.

We asked which of the topics covered over the past three years were most important and these were the top five topics for survey respondents:

  1. Survivorship
  2. Advocacy
  3. Side Effects
  4. Personalized Medicine
  5. Clinical Trials and Support

When asked how they used the information from #gyncsm chats after the chat, the top response was advocating for themselves or others (58%). Also of note, 29% took part in an online support group and used a resource found in our blog posts. 

 

When we asked how we can better help the community and what topics we should discuss, here's some of what we learned:
  • Sometimes the time is either too early or too late.
  • Sometimes the chat is too quick for a meaningful discussion.
  • We should highlight other gyn cancers - endometrial/uterine, cervical were mentioned in particular. Continue to talk about clinical trials and genetics.
  • Talk about health care disparities and outcomes for women of color.
  • Talk about dealing with grief from the loss of friends.
  • Talk about sexuality after treatment.
  • Talk about what is important to younger patients.

We also asked respondents to share their thoughts on our #gyncsm chat/community and how it has has impacted their attitude toward their own health. Some of the things we heard are that #gyncsm provided:
  • Hope.
  • Made me feel part of the community.
  • Encouraged me to take more ownership in my own preventive health and advocacy for others.
  • Appreciate the range of resources offered.
  • Feel more empowered, less alone.
  • Led me to follow up more on some of my side effects and secondary challenges.
  • Wish #gyncsm could be leveraged into a new non-profit for all GYN cancers.
  • I felt like I was alone... there were no support groups near me. #gyncsm made me feel a part of a community.
But we also heard:
  • It is challenging for the hashtag to cover both advocacy/activism AND patient/survivor support - this is a common problem with other disease hashtags.
  • There needs to be more equal support for other cancers.

Lastly we wanted to know how individuals find out about #gyncsm. Respondents found us via:
  • Twitter
  • Other cancer chats
  • Facebook
  • Dee's Blog
  • From a friend
  • Researching cancer
  • Followed @btrfly12
  • NED twitter handle
  • Randomly found the #gyncsm chat
  • Smart Patients

Thank you to all who took this survey and for your continued support. We are using the information from the survey as we make our plans for next year. Remember if you have any other comments or concerns feel free to reach out to gyncsm@gmail.com.

Dee
#gyncsm Co-founder

Thursday, 1 September 2016

Awareness and Advocacy - Sept Round-up


Awareness months are a wonderful opportunity to build momentum around a health cause. Here are lots of resources and information about the great things you can get involved with for Gynecologic Cancer Awareness Month and Ovarian Cancer Awareness Month. We'll add to this post as the month goes along. You can also check out our RESOURCES section for overall and cancer-specific organizations and resources that are helpful year-round.

Gynecologic Cancer Awareness Month

Foundation for Women's Cancer
Cervivor (Cervical Cancer Awareness Month is January, so love seeing them join along)
  • Main Hashtags: #gcam #gyncsm #preventcc 
National Cervical Cancer Coalition (Cervical Cancer Awareness Month is January, so love seeing them join along)
    UK Organizations:
    Virtual Events:
    Places to Find Personal Stories:
    Gynecologic and Ovarian Cancer Symptom Images to Share:

        Ovarian Cancer Awareness Month

        Presidential Proclamation - National Ovarian Cancer Awareness Month, 2016
        http://go.wh.gov/ZkDRGY

        Foundation for Women's Cancer
        Ovarian Cancer Research Fund Alliance
        National Ovarian Cancer Coalition
        SHARE Cancer Support
        • Main Hashtags: #TealTuesday #ovariancancer #gyncsm
        Virtual Events:
        Places to Find Personal Stories:
         

            Hereditary Breast and Ovarian Cancer Week (9/25-10/1) and Previvor Day (9/28)

            FORCE


            Christina Lizaso
            co-founder #gyncsm

            Friday, 8 July 2016

            Spirituality and Quality of Life - July 13th #gyncsm Chat



            This month the #gyncsm community will be discussing Spirituality and Quality of Life. Joining us will be Meredith Gould, PhD (@MeredithGould), who co-founded and co-moderates the monthly #hlthsp (Health and Spirituality) chat. Meredith is a writer, sociologist and digital strategist with decades of communications experience in healthcare and faith-based organizations. Her most recent book is titled "Desperately Seeking Spirituality".

            The topic questions we'll cover are:

            T1: To frame our discussion: What does spirituality mean to you? How might it differ from religion?

            T2: How do you personally define "quality of life"? What role does spiritual life or practices play for you?

            T3: What connections have you experienced btwn spirituality and your overall quality of life? Your mental health? Physical health?

            T4a: What impact has receiving/living with a critical diagnosis had on your spirituality? How about your spiritual practices?
            T4b: What impact has your spirituality and spiritual practices had on your experience with a critical diagnosis and treatment?

            T5: How/who/what supports your spiritual awareness? What are some helpful digital/social media resources for spiritual support?


            In a recent ASCO (Amercian Society of Clinical Oncology) Post article entitled "Integrating Spirituality Into Palliative Care Services: A conversation with Dr Christina Pulchalski MD", Dr Puchalski speaks of a 2009 paper produced after a Consensus Conference which identified points of agreement about spirituality as it applies to health care and made recommendations to advance the delivery of quality spiritual care. That paper makes for an interesting "deep dive" read into this topic.

            There was also an abstract on this topic released in conjunction with the 2016 ASCO Meeting: Survey of spiritual quality of life among survivorship and distress guidelines. Its conclusion, "Spiritual quality of life is addressed by current practice guidelines of psychosocial distress, but survivorship guidelines provide little direction for screening or management." Fascinating that spirituality only enters the discussion here in terms of "distress".

            We hope you will join us Wednesday, July 13 at 9pmET as we discuss this important aspect of support and care of cancer patients and anyone who has faced a critical diagnosis.

            If you'd like to check out #hlthsp, you can follow @hlthsp on Twitter and their chats are held on 3rd Wednesdays at 9pmET. The next #hlthsp chat is 7/20 and the topic will be a continuation of the Spirituality and Quality of Life discussion started this month on #gyncsm.

            Dee & Christina
            Co-founders #gyncsm Chat

            Wednesday, 8 June 2016

            June 8, 2016: What's New in Gyn Cancer Research

            Thirty-four #gyncsm community members chatted about What's New in Gyn Cancer Research.  Our discussion focused on research presented at the Society of Gynecologic Oncology Annual Meeting (#SGOmtg) held March 19-22 in San Diego, the American Association for Cancer Research Annual Meeting (#AACR16) held April 16-20 in New Orleans, and the American Society of Clinical Oncology Annual Meeting (#ASCO16) held June 3-7 in Chicago.

            You may find the transcript here and the chat analytics here. 

            We began our chat by remembering our friend and supporter of #gyncsm, Jody Schoger, #bcsm co-founder. She was an amazing advocate. 

            Topic Questions / Sample Response Tweets: 

            T1:Do you research new treatments and studies online? Do you follow scientific meetings like #SGOmtg, #AACR16 and #ASCO16? 

            • I participate in twitter to inform patients and families of key findings from meetings using #SGOMtg #ASCO16 #AACR16
            • A caution in keeping up with research is how long it can take for studies to lead to any change in practice guidelines
            • Plus I want to be prepared with what options I will have if I recur again
            • I find @ASCOPost emails useful.

            T2:GOG 252 did not support a previous study which showed IP chemo benefit (tough treatment for many). How does this change things? 
            • #ASCO16 session on GOG252 Walker: Median PFS all three arms GOG252 similar
            • There is still a benefit for IP chemo - demonstrated in 3 large randomized trials We need to understand who benefits most
            • Yes, Dr Gourley mentioned 3 Pos studies(GOG 104,114,172), 1 neg(252)
            • I feel more confident telling patients that if they want the benefits of GOG172, we have to at least try the same regimen 
            • #ASCO16 session on GOG252 Mackay-“unresolved issues” 
            T3:In the hot topics of immunotherapy, precision medicine, and genetics, which #SGOmtg/ #AACR16/ #ASCO16 research excited you? 
            • https://t.co/DfjMW5ZPwP adv endometrial cancer : everolimus, letrozole,metformin showed clinical benefit in ph 2study 
            • I'm very excited about the interest & research on hereditary cancers and how to use this to guide targeted therapy-new options! 
            • Pembrolizumab:well tolerated, showed antitumor activity pts w/ PD-L1+ adv cervical squamous cell cancer.https://t.co/P5KsDdtTUA
            • Precision medicine for Gyn disease is finally taking root. It not only bevucizumab anymore
            • Kurian: Genes mutations in #ovca article https://t.co/O1mgn5zqoc
            •  Liquid biopsies (look for circulating tumor DNA in blood) https://t.co/PUROem0e7N 4 screening and during treatment talked about 
            • There was a clear theme of trying to find out who are the responders to a given Rx - understanding the pts that benefit the most
            T4: What studies reported at #ASCO16 in palliative care, survivorship, and psychosocial research could help gyn cancer survivors? 
            • The data on early involvement of palliative care should be able to be extrapolated to gyn cancer patients and caregivers
            • QOL may predict survival in recurrent #ovca @ASCOpost -https://t.co/te0NvFAkPJ 
            • Real studies on improving chemo induced. Neuropathy with PT
            • Qol: older long term #ovca survivors better QOL than younger https://t.co/OGKtr3t0oi
            • It was great to see presentations beyond standard chemo treatment. ASCO. It's not just about chemo
            T5: As "patient-centered" research becomes more accepted, what do you see as the role of the patient in future cancer research?
            • Been great to see White House precision medicine efforts. workshop this week: Engaging participants as partners in research
            • Let's start with adding quality of life components to all studies.
            • Being more patient-centered means looking beyond overall survival endpoints. Also need patients in design of studies to reach.
            • This from #SGOmtg patient-centered research: Accepting treatment w/ Side Effects change as Goals Change https://t.co/xhY9Wg1FRn
            • Patients see so much in the practical side of clinical trials that trial designers don't think about.
            • I would love to see advocates on irb. And involved in trial design

            Our next #gyncsm chat is on  Wednesday  July13th  at 9pmET when we will discuss Spirituality and Quality of Life with guest @MeredithGould of #hlthsp. We hope you can join us. 

            Remember patients and caregivers are invited to continue our discussion on the Smart Patients platform at https://t.co/dFCf1Mcahw. 

            See you next month!

            Dee Sparacio
            Co-founder #gyncsm Community and Chat

            Resources:
            @SGO_org Society of Gynecologic Oncology: #SGOmtg Abstracts and Late-breaking Abstracts https://t.co/vjzYlqOTC1

            @AACR American Association for Cancer Research: #AACR16 Abstracts https://t.co/2sZ6G7QveL

            @ASCO American Society of Clinical Oncology: #ASCO16 abstracts https://t.co/3vruaogIUV

            "Roundup of #OvarianCancer Abstracts From #SGOmtg on Women’s Cancer" https://t.co/7z5UlcDx17 via @ascopost

            @ocrfa statement on GOG 252 https://t.co/XTjyzfOpw9

            key abstracts at #ASCO16 Gyn Onc at ASCO 2016: Ovarian Cancer https://t.co/t1krzp6ymx via @YouTube

            Abstracts #ASCO16 Gyn Onc at ASCO 2016: Cervical Cancer https://t.co/780LCAOh72 via @YouTube

            abstract review from #ASCO16 - Gyn Onc at ASCO 2016: Endometrial Cancer https://t.co/Dsh7AdyArv via @YouTube

            exercise and neuropathy: https://t.co/LZwUSbWVAi

            Engaging participants as partners in research - Workshop Storify https://t.co/RrRVpndnQd via @stanfordmedx

            researchers going directly to metastatic breast cancer patients. https://t.co/iV2dnxfzIY?


            Friday, 4 December 2015

            Looking Back ...Looking Forward - December 9, 2015 Chat


            Over the past twelve months the #gyncsm community has grown. We've partnered with Smart Patients, included more guests in our chats, and conducted a joint chat with the #hpm community. We've seen an increase in the number of chat participants (averaging 47 participants per chat) and had well over 1 million impressions in a majority of our chats.

            Embracing this season of reflection, this month's #gyncsm chat topic is Looking Back… Looking Forward. Join us on Wednesday December 9,2015 at 9pm ET/8CT/6PT.

            We'll give our participants - survivors, caregivers, advocates, health care providers and researchers alike - a chance to Look Back at their year on a personal level and as part of our community. Then we will Look Forward to 2016 and what new things we can can do as individuals and as a chat community.

            Our topic questions will include:

            T1: What are some things you did in 2015 that brought you satisfaction? What steps have improved your overall quality of life? 

            T2: Is there something you wish you did differently this year? Do you have plans to try something new in 2016?


            T3: What has #gyncsm done well? What do you find most helpful from our chats, posts, blog, etc.?


            T4: How might we enhance the #gyncsm community for ALL participants? What would you like to see from #gyncsm in 2016?

            T5: How might #gyncsm foster collaboration in the women's cancer space? Topics you'd like to see covered? Ideas to get more people involved?
             

            We hope you will join us and share your past experiences and your hopes for the year to come and for the #gyncsm community.


            Dee
            #gyncsm co-moderator


            Wednesday, 14 October 2015

            Oct 14,2015 Open Mic Chat

            This Open Mic chat focused on topics of interest to our participants. It was great to see our regulars and some new faces. It was a lively hour with 35 participants and 406 tweets in the hour. You may find the transcript here and additional analytics here.

            The initial question was about returning to work.
            Advice included recruiting students to help, drink lots of water, take breaks, eat high energy snacks such as nuts, raisins and to take a nap when she got home.

            Then a good source on immuno-oncology was shared along with some comments on Lynch Syndrome.


            The discussion then turned to IP chemotherapy for ovarian cancer. Studies show IP chemotherapy provides an improved overall survival compared to IV chemotherapy.


            The recent report on the safety of Hormone Replacement Therapy for epithelial ovarian cancer survivors was shared and discussed.


            Next the topic of annual pelvic exams and a possible U.S. Preventive Services Task Force recommendation was brought up.



            We also discussed screening, family history, gyn awareness month activities, a timeline chart of long-term side effects post-chemo & radiation, risk of ovarian cancer in young women, surgical menopause and which supplements are recommended after BSO(bilateral salpingo-oophorectomy). 

             A link to a Brief survey for Cancer Survivors: How do you prefer to receive test results?buff.ly/1VTe1tm was also shared.

            Remember you can continue our conversation on Smart Patients (https://www.smartpatients.com/gyncsm)

            We look forward to seeing you again next month on November 11, 2015 at 9pmE/8pmC/6pmP as we talk about Exercise and Nutrition. We are lining up some guests to share their expertise so the hour should be filled with helpful information. See you then!

            Dee
            Co-Moderator

            Resources

            IKCC website 10forio.com Understanding Immuno-oncology for Kidney Cancer

            The Underutilization of Intraperitoneal Chemotherapy for #OvarianCancer medscape.com/viewarticle/85…

            Adjuvant Hormonal Therapy Is Safe in Epithelial Ovarian Cancer cancertherapyadvisor.com/gynecologic-ca…

            Do Women Need an Annual Pelvic Exam pbs.org/newshour/rundo…

             Book: 100 Questions & Answers About Ovarian Cancer by @drdonsdizon @womenofteal  jblearning.com/catalog/978128…

            @NCICancerStats #OvarianCancer fact sheet: go.usa.gov/yUpP

            What’s an Ashkenazi woman to do? Jewish Telegraphic Agency jta.org/2015/10/14/lif…

            Friday, 7 August 2015

            Dealing with the Short and Long Term Side Effects of Gyn Cancer Treatments - August Chat

            In last year's survey we asked participants what topics we should cover during this year's chats. A large number of survey takers chose Dealing with Short and Long Term Side Effects. Women diagnosed with a gynecologic cancer may have surgery, chemotherapy, radiation or targeted therapies. All of these treatments may lead to side effects - some more common than others. We look forward to sharing information about side effects and ways to deal with them on Wednesday August 12, 2015  ( 9pm EST) .

            Here are chat questions:
            T1: Let’s start w/ surgery side effects...  Which affected you most? Which do patients say are most impactful? Tips to address?

            T2: Now let's talk about chemo. What were your side effects? Which are common? How aware of side effects are patients before start?

            T3: What are some of the side effects of radiation? Which did you experience? What are patients most concerned about?

            T4: For targeted therapy (TT) - Oliparib, Avastin, etc. - what are the side effects? Different from chemo?

            T5: What side effects persist? Have you talked to your provider about them? Other side effects we haven't covered so far?

            T6: What impacts are you willing to deal with to get more effective treatment? Have we seen changes in how side effects are managed?


            Check out the information on side effects on the Patient Resource (@PRPCancerGuide) website (https://www.patientresource.com/Gynecologic_Side_Effects.aspx).

            We look forward to having you join us for a lively and informative discussion.

            Dee
            #gyncsm co-moderator

            Monday, 13 April 2015

            Survivor's Story: GTD and Me – A Story of Diligence, Persistence, and Grace

            During the recent tweet chat (#CancerFilm) which took place during the viewing of the documentary the Emperor of All Maladies, Christina conversed with Katie Smith, who was diagnosed with GTD (Gestational Trophoblastic Disease). Gestational trophoblastic disease (GTD) is defined by the National Cancer Institute (NCI) as a group of rare diseases in which abnormal trophoblast cells grow inside the uterus after conception. Trophoblast cells help to connect the embryo to the uterine wall and help to form the placenta. GTD, in most cases, is benign but some cases may be malignant and spread to nearby organs. Please see the NCI site for additional information. We are pleased to have Katie share her story with our community. 


            GTD and Me
            A Story of Diligence, Persistence, and Grace

            I was 28 years old in the winter of 2005.  I had a beautiful one year old son that my husband and I had waited on for almost four years, a new job, and was excited about possibly having more children in the future.  Little did I know my world was about to be turned upside down.

            After having my son, my monthly menstrual cycles became quite painful.  But, I just attributed it to getting older.  I also began having a thick discharge, but attributed it to post nasal drip (I have horrible allergies and thought that was the culprit).  In February 2005, I went to the doctor about the painful periods and an ultrasound was performed.  The doctor saw something in my uterus, but stated it was a fibroid.  Traditionally, fibroids can cause intense periods so this made sense.  I was sent home.

            The next month, I noticed that my “pregnancy nose” had returned.  You know – that ability to smell someone eating a cheeseburger in the neighboring town.  At that point, I got a little scared.  While I wanted more children, I wasn’t prepared to have one now.  When I took a home pregnancy test, it showed faintly positive.  So, off to my OB/GYN doc I went.

            The blood pregnancy test indicated that I had been pregnant but had a miscarriage.  This was devastating!  According to the doctor, my HCG levels were low which indicated that there may still be remnants in the fallopian tubes.  I was given a very light dose of Methotrexate to help flush out any remaining items.  I was again sent home, but was asked to come back in a couple of days for another HCG level check.

            But, when I came back a couple of days later, my HCG levels were starting to creep up.  I was asked to come back in two more days for another check.  This went on for about 1 ½ months (including a stronger dose of Methotrexate thrown in there).  For some reason, my levels would not go down.  At this point, my OB/GYN doctor became concerned.  She said, “I really don’t think this is cancer, but I want you to go see my doctor.  He is a Gynecological Oncologist who can rule out cancer and figure out what this is.”

            Dr. Don Hall, the Gynecological Oncologist, immediately sent me for an ultrasound.  The Ultrasound Tech stated, “I see a fibroid in there.  That’s it.”  But, Dr. Hall had a feeling that this was more than just a fibroid.  After multiple urine and blood tests, along with a PET scan, the diagnosis was found.  While all of this was going on, I became engrossed in finding out what this could be.  I stumbled across a Gynecological Disease website and found something called “Gestational Trophoblastic Disease”.  The symptoms sounded like the ones I had been experiencing.  Could it really be cancer?

            It was a Friday afternoon and I was called in for my results.  With my mother on one side of me and my husband on the other, Dr. Hall delivered the news.  I had a Placental Site Trophoblastic Tumor, which is in the GTD family of cancers.  Less than ½ of 1 percent of women have this type of tumor, and it forms where the placenta attaches to the uterus.  He had already scheduled my hysterectomy for the following Wednesday.  I would be in the hospital for 3 days and on leave for 6 weeks minimum.  I would have a long scar starting from my belly button down, and they may have to remove part of my intestine.  The PET scan had indicated the tumor had protruded through the uterus and was wrapped in the intestine.

            Part of me was relieved to have a diagnosis but the other part of me was terrified.  In addition, our insurance was completely maxed out (this was in the day of annual maximum amounts and before the ACA).  We would have to pay for the entire surgery and any other treatments that I would have to go through.  Funny enough-I didn’t worry about the money part.  I just wanted to be alive to see my son grow up.

            When Dr. Hall went in to do the surgery, he discovered that the tumor had not protruded but was fully contained in the uterus.  It was removed and sent off for growth rate testing.  If the growth rate was low, no further treatment would be necessary.  If the growth rate was high, I would have to take chemotherapy and radiation.  In addition, it was discovered I had really bad endometriosis and one of my ovaries was removed because it was badly damaged. 

            The results of the growth rate testing showed that the tumor was growing at a slow rate.  However, I had to come back every month for HCG testing.  Each time I went it, I would get very anxious.  I had ghost symptoms constantly and stayed panicked.  But, the first year went by with no increase in HCG.  In July 2015, I will be 10 years cancer free. 

            There is a very slight chance it could recur as lung cancer, with an even slighter chance of breast cancer occurrence.  But, thanks to God, the concern of my OB/GYN doctor Rebecca Walker and the diligence and persistence of Dr. Hall,  I’ve been able to experience 11 years of bliss with my son. 

            What can you take from this story:  Listen to your body.  It will tell you when something is wrong.  If something is wrong, don’t blow it off.  Have it checked out – it might just save your life.

            - Katie Smith (@katielizsmith)


            Thank you so much Katie for sharing your story with us. 

            Dee 
            #gyncsm co-moderator 


            Wednesday, 8 April 2015

            SGO Recap & ASK the DOC - April 8, 2015 Chat

            Twenty-nine participants joined us to discuss the latest research news from the SGO Annual Meeting held in March. Contributing to our discussion were Dr. Don S. Dizon and Dr. Ann Becker-Schutte, two of #gyncsm's healthcare moderators, as well as Dr. William Winter (NED the Band), Dr. Shannon Westin, Dr. Matthew Katz, Dr. Stephanie Blank and Lisa M Guzzardi, RN.

            You may find the transcript here and analytics here. 

            Some of the questions and responses during the chat are below:


            T1: Pls comment on the study at SGO you found of most note. Was it OC FANG vaccine/ GOG 213 studies/ other?





            T2: Which ovarian cancer research results are most exciting to you? Immunotherapy? Bevacizumab? Parp inhibitors?


            T3: Pls discuss the implications of Dr Joura’s HPV study on cervical cancer & the Circulating Tumor Cells / Bevacizumab study. 

            @gyncsm: studies re: BRCA 1) majority of BRCA carriers don’t have family hx 2) most ovarian cancer patients don’t know BRCA status.  
            T4: How will these BRCA studies impact surveillance, ed, treatment?


            T5: Now we open the chat for questions from our participants re: news they heard from the SGO mtg.

            • T5: any studies reveal benefit regarding endo ca recvng maint chemo Stage IIIc2 currently NED     A:Nothing yet - we need more maintenance studies for gynecologic cancers
            • T5: Question - any radiation oncology news from SGO?   A:there was very little major research on #radonc this year
            • T5: Does current genetic testing for #OC include mutations like TP53,RAD51D,etc ? Or just BRCA?Is this imp ?   A:#gyncsm panel testing test for many more mutations. should speak w genetic counselor. some is imp, some for future #sgo2015   
            • T5:Thoughts on how should patients/loved ones approach new study findings?   A:Open mindedness and always validate its credibility too


            Our next chat will be at 9pm EST on May 13, 2015 . We will be joined by Kelly Mellott (@HelomicsCancer) as we discuss Personalized Medicine Advances for GYN Cancers. 


            Patients & caregivers are invited to continue our discussion on the Smart Patients platform at https://www.smartpatients.com/partners/gyncsm.


            Dee
            Co-moderator #gyncsm chat


            Resources shared during the chat: 

            Highlights from the SGO Mtg
            http://www.cancernetwork.com/conference-report/top-highlights-2015-sgo-annual-meeting

            @SGO_org paper on end-points in Clinical trials
            https://t.co/gNiU6SUICP

            Incidental power morcellation of malignancy: a retrospective cohort study. - PubMed - NCBI 
            http://t.co/pJOVG9XCfr

            Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer 
            http://jama.jamanetwork.com/article.aspx?articleid=2214084#.VSXXv-chiQ8.twitter

            Advanced Cervical Cancer and Circulating Tumor Cells treated with Bevacizumab
            http://www.targetedonc.com/conference/sgo-2015/Patients-with-Advanced-Cervical-Cancer-and-Circulating-Tumor-Cells-Treated-With-Bevacizumab-Show-Improved-OS

            Postmenopausal HRT & use of estradiol plus levonorgestrel IUD is assoc with increased risk of fallopian tube cancer
            http://t.co/ppFIu9EDou

            Additional Resources:

            SGO Highlights:

            AVASTIN GOG 213
            OncLive “overall survival (OS) of nearly 5 months compared with chemotherapy alone for women with platinum-sensitive recurrent ovarian cancer, according to results from the phase III GOG0213: “




            Surgeon vs CT results of size of tumors left behind.

            Fosbretabulin /Avastin
            OXiGENE Announces Presentation of Phase 2 Data Confirming That Addition of Fosbretabulin to Bevacizumab Significantly Increases Progression-Free Survival in Recurrent Ovarian Cancer

            Immunotherapy

            IP chemo advantages

            Recommendations for the prevention of ovarian cancer : SGO

            PARP inhibitor - olaparib (Lynparza)

            diagnostic tool- bracaAnalysis

            FANG vaccine trial / Immunotherapy



            Endometrial Cancer -Cediranib
            http://www.targetedonc.com/conference/sgo-2015/Cediranib-Monotherapy-Safe-Effective-in-Endometrial-Cancer

            Supplements / Vitamins Are they helpful? May 8, 2019 Chat

            We were pleased to have Stacy Kennedy MPH,RD (@stacykennedyrd) join us for this informative chat on vitamins and supplements.  You may find ...